Plasmids – vectors for gene therapy
Authors:
Open Access
- 1 January 2017
- journal article
- Published by Walter de Gruyter GmbH in Advancements of Microbiology
- Vol. 56 (2) , 214-225
Abstract
The first confirmed transfer of genetic material in human was performed in 1990. Ever since, gene therapy was considered to be one of the best promising treatments of genetic diseases. The sine qua non of successful gene therapy are efficient genetic vectors. Recently, the most frequently used vectors in clinical trials for genetic therapies are virus-based and plasmid-based. A range of features makes plasmids useful for gene therapy, however, they have also some characteristics which make it difficult to consider plasmids as ideal vectors. The main goal of this article is to address and describe these unfavourable factors. 1. Introduction. 2. Natural modification of DNA as an obstacle to the use of plasmids for gene therapy. 3. Plasmid DNA usage safety. 4. Plasmid DNA entry into eucaryotic cells. 5. Post-entry fate of plasmid DNA in eucaryotic cells. 6. pDNA-based gene therapies. 7. Alternative routes of development of pDNA-based gene therapies. 7.1. Baktofection. 7.2. Alternative Gene Therapy – AGT. 7.3. Hydrogels. 7.4. DNA minicircles. 7.5. DNA ministrings. 8. Summary 1. Wstęp. 2. Naturalna modyfikacja DNA jako przeszkoda w stosowaniu plazmidów w terapii genowej. 3. Bezpieczeństwo użycia plazmidowego DNA. 4. Wprowadzenie pDNA do komórek eukariotycznych. 5. Los plazmidowego DNA po wprowadzeniu do komórek eukariotycznych. 6. Terapie genowe bazujące na pDNA. 7. Inne kierunki rozwoju terapii genowych opartych na plazmidowym DNA. 7.1 Baktofekcja. 7.2. Alternatywna terapia genowa (Alternative Gene Therapy – AGT). 7.3. Hydrożele. 7.4. Minikoliste DNA. 7.5. Mininici DNA. 8. PodsumowanieKeywords
This publication has 97 references indexed in Scilit:
- New Generation of Plasmid Backbones Devoid of Antibiotic Resistance Marker for Gene Therapy TrialsMolecular Therapy, 2011
- Cytoplasmic DNA innate immune pathwaysImmunological Reviews, 2011
- Sustained, high transgene expression in liver with plasmid vectors using optimized promoter‐enhancer combinationsThe Journal of Gene Medicine, 2011
- CpG islands and the regulation of transcriptionGenes & Development, 2011
- Hydrodynamic Gene Delivery and Its Applications in Pharmaceutical ResearchPharmaceutical Research, 2010
- Optimizing the generation of stable neuronal cell lines via pre-transfection restriction enzyme digestion of plasmid DNACytotechnology, 2010
- The impact of intragenic CpG content on gene expressionNucleic Acids Research, 2010
- Lentiviral Vectors in Gene Therapy: Their Current Status and Future PotentialArchivum Immunologiae et Therapiae Experimentalis, 2010
- Electroporation-mediated delivery of a naked DNA plasmid expressing VEGF to the porcine heart enhances protein expressionGene Therapy, 2009
- Progress and problems with the use of viral vectors for gene therapyNature Reviews Genetics, 2003